Sumitomo Seika Chemicals Company, Limited. (TYO:4008)
Japan · Delayed Price · Currency is JPY 1,558.00
+8.00 (0.52%)
Aug 14, 2026, 3:30 PM JST
TYO:4008 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 153,182 | 148,354 | 147,571 | 142,986 | 143,041 | 115,583 | |
Revenue Growth | 4.74% | 0.53% | 3.21% | -0.04% | 23.76% | 11.94% |
Cost of Revenue | 116,031 | 112,919 | 116,890 | 114,979 | 112,905 | 89,434 |
Gross Profit | 37,151 | 35,435 | 30,681 | 28,007 | 30,136 | 26,149 |
Selling, General & Admin | 18,522 | 18,097 | 17,344 | 15,766 | 17,010 | 15,486 |
Research & Development | 3,050 | 2,873 | 2,624 | 2,711 | 2,670 | 2,590 |
Operating Expenses | 21,572 | 20,970 | 19,968 | 18,477 | 19,680 | 18,076 |
Operating Income | 15,579 | 14,465 | 10,713 | 9,530 | 10,456 | 8,073 |
Interest Expense | -289 | -280 | -286 | -397 | -286 | -245 |
Interest & Investment Income | 460 | 484 | 649 | 844 | 558 | 168 |
Currency Exchange Gain (Loss) | 1,737 | 529 | 88 | 280 | 44 | 676 |
Other Non Operating Income (Expenses) | 485 | 50 | -59 | -11 | 156 | 242 |
EBT Excluding Unusual Items | 17,972 | 15,248 | 11,105 | 10,246 | 10,928 | 8,914 |
Gain (Loss) on Sale of Investments | 1,380 | 831 | 122 | 37 | 429 | 26 |
Gain (Loss) on Sale of Assets | 1 | 1 | - | 2 | - | - |
Asset Writedown | -1,153 | -1,476 | -1,502 | -834 | -109 | -488 |
Other Unusual Items | -3,208 | -2,927 | -1,403 | -730 | - | - |
Pretax Income | 15,085 | 11,677 | 8,322 | 8,721 | 11,248 | 8,452 |
Income Tax Expense | 5,190 | 4,000 | 2,361 | 2,555 | 2,624 | 2,499 |
Earnings From Continuing Operations | 9,895 | 7,677 | 5,961 | 6,166 | 8,624 | 5,953 |
Minority Interest in Earnings | - | - | - | - | -32 | -58 |
Net Income | 9,895 | 7,677 | 5,961 | 6,166 | 8,592 | 5,895 |
Net Income to Common | 9,895 | 7,677 | 5,961 | 6,166 | 8,592 | 5,895 |
Net Income Growth | 120.62% | 28.79% | -3.33% | -28.24% | 45.75% | -17.19% |
Shares Outstanding (Basic) | 65 | 65 | 66 | 67 | 67 | 69 |
Shares Outstanding (Diluted) | 65 | 65 | 66 | 67 | 67 | 69 |
Shares Change | -0.64% | -1.21% | -1.53% | -0.43% | -1.80% | -0.38% |
EPS (Basic) | 151.97 | 117.48 | 90.12 | 91.80 | 127.36 | 85.81 |
EPS (Diluted) | 151.97 | 117.48 | 90.12 | 91.80 | 127.36 | 85.81 |
EPS Growth | 123.31% | 30.36% | -1.83% | -27.93% | 48.43% | -16.88% |
Free Cash Flow | - | 5,093 | -5,977 | 3,797 | 1,800 | 5,388 |
Free Cash Flow Per Share | - | 77.94 | -90.36 | 56.53 | 26.68 | 78.43 |
Dividend Per Share | 44.000 | 44.000 | 40.000 | 40.000 | 40.000 | 24.000 |
Dividend Growth | 10.00% | 10.00% | 0% | 0% | 66.67% | 20.00% |
Gross Margin | 24.25% | 23.89% | 20.79% | 19.59% | 21.07% | 22.62% |
Operating Margin | 10.17% | 9.75% | 7.26% | 6.67% | 7.31% | 6.98% |
Profit Margin | 6.46% | 5.17% | 4.04% | 4.31% | 6.01% | 5.10% |
Free Cash Flow Margin | - | 3.43% | -4.05% | 2.66% | 1.26% | 4.66% |
EBITDA | - | 19,989 | 16,450 | 15,277 | 15,553 | 12,969 |
EBITDA Margin | - | 13.47% | 11.15% | 10.68% | 10.87% | 11.22% |
D&A For EBITDA | 5,471 | 5,524 | 5,737 | 5,747 | 5,097 | 4,896 |
EBIT | 15,579 | 14,465 | 10,713 | 9,530 | 10,456 | 8,073 |
EBIT Margin | 10.17% | 9.75% | 7.26% | 6.67% | 7.31% | 6.98% |
Effective Tax Rate | 34.41% | 34.26% | 28.37% | 29.30% | 23.33% | 29.57% |